NEW DELHI: The world’s largest drug company Pfizer and French drug company Sanofi Aventis are in the race to pick up a significant slice of Wockhardt’s biotechnology business, said a person involved in the proposed deal. Analysts say if there is a complete buyout, the deal could be in the region of Rs 250 crore.
